baber/WOPTO huggingface dataset:
Patent AU-2020233701-A1 (AU)
Title: Electrically driven shelving system with a LiDAR operating system
Inventor: PARKER BRIAN
IPC: G01V8/10
Filed: 2020-05-27
Abstract: A mobile shelving system comprising a plurality of shelving bay rows including at least one 
driven shelving bay mounted on a track and a LiDAR scanning arrangement scanning the 
outside of the shelving system to detect any object reflecting the light, determining where that 
break has occurred and acting on the shelving system to move it at that point to open up an 
aisle.
Patent AU-2020244510-A1 (AU)
Title: Fish transfer system and method
Inventor: PEIRSON WILLIAM LESLIE
IPC: E02B8/08
Filed: 2020-09-30
Abstract: Disclosed is a system and method for transferring fish past a barrier between an upper 
and lower body of water, including an inlet conduit 11 connecting the upper body to a 
transfer chamber13 adjacent the lower body, a delivery conduit 15 connecting the transfer 
chamber 13 to a level above the surface of the upper body, a valve 12 between the inlet 
conduit and the transfer chamber, and a gate 14 between the transfer chamber 13 and 
the lower body. The inlet conduit 11 holds sufficient water so that, once the gate 14 is 
closed and the valve 12 is opened, fish in the transfer chamber 13 are transported with 
the water in the transfer chamber through the delivery conduit 15 to an outlet 16.
1/4 
16 
10 11 
INLET 
DELIVERY CONDUIT 
CONDUIT 
15 
12 
TRANSFER 
CHAMBER 
Figure 1 
14
Patent AU-2020246448-A1 (AU)
Title: Anti-HER2 antibody-pyrrolobenzodiazepine derivative conjugate
Inventor: HARADA NAOYA
IPC: C12P21/08
Filed: 2020-03-24
Abstract: A novel anti-HER2 antibody-pyrrolobenzodiazepine (PBD) derivative conjugate; a medicine using the antibody-drug conjugate that has a therapeutic effect on a tumor; and a method for treating a tumor using the antibody-drug conjugate or the medicine.
Patent AU-2020249341-A1 (AU)
Title: Compound for the sequestration of undesirable antibodies in a patient
Inventor: SMRZKA OSKAR
IPC: C07K14/05
Filed: 2020-03-23
Abstract: The present invention provides a compound for the sequestration of undesirable antibodies (e.g. related to an autoimmune disease) in a patient. The compound comprises an inert biopolymer scaffold and at least a first peptide n-mer of the general formula P ( - S - P )
Patent AU-2020252003-A1 (AU)
Title: Durable and dispersible creped mutli-ply tissue
Inventor: VOGT KEVIN JOSEPH
IPC: A61K8/81
Filed: 2020-03-27
Abstract: Disclosed are multi-ply tissue products comprising a non-crosslinked binder that are durable and dispersible. The products generally have a Slosh time less than 2 minutes, such as less than about 60 seconds, such as less than about 45 seconds. Surprisingly, the foregoing Slosh times are achieved despite the tissue products having relatively high cross-machine direction (CD) wet tensile strength, such as greater than about 100 g/3". Typically, increasing wet tensile strength, particularly wet CD tensile strength, negatively effects dispersability and increases Slosh time. Despite this trend, the present invention surprisingly provides a tissue product having a relatively high degree of wet strength and good dispersability.
Patent AU-2020264306-A1 (AU)
Title: Ambient Bed Having a Heat Reclaim System
Inventor: ALLETTO JR EUGENE
IPC: A61G7/057
Filed: 2020-11-04
Abstract: : 
A bedding system (20) is provided that includes a fan box layer (22) having a plurality 
of ducts (34), each of the ducts being in communication with a fan (32) configured to 
move air out of the duct and into an area surrounding the bedding system. A capacitor 
layer (24) is positioned above the fan box layer. The capacitor layer includes a plurality 
of outlet ports (42), each of the outlet ports being in communication with one of the 
ducts. A mattress layer (26) is positioned above the capacitor layer. The mattress layer 
includes a bottom portion having a plurality of first holes (60) that are each in 
communication with at least one of the outlet ports and a top portion having a plurality 
of second holes (62) that are each in communication with one of the first holes. The 
top portion defines a sleep surface (28).
WO 2015/106258 PCT/US2015/011179 
1/12 
62 
20 
68 
40 
28 
70 
32 
0.30 
22 
26 24 
FIG. 1
Patent AU-2020266741-A1 (AU)
Title: Halogen-free, non-intumescent, fire retardant coating composition
Inventor: RHOADES TOOLIKA AGRAWAL
IPC: C09D7/61
Filed: 2020-04-24
Abstract: The invention relates to a halogen-free, non-intumescent, fire retardant coating composition comprising (a) a (meth)acrylate polymer, wherein the glass transition temperature (T
Patent AU-2020267286-A1 (AU)
Title: Isolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
Inventor: EMMANUEL EYAL
IPC: C12N15/82
Filed: 2020-11-13
Abstract: Provided are isolated polynucleotides which comprise a nucleic acid sequence at least 80 % 
identical to SEQ ID NO: 321, 1-320, 322-480, 793-2945 or 2946; isolated polypeptides which 
comprise an amino acid sequence at least 80 % homologous to SEQ ID NO: 517, 481-516, 518
792, 2947-4662 or 4663, nucleic acid constructs comprising same, transgenic cells and plants 
expressing same and methods of using same for increasing yield, biomass, growth rate, vigor, oil 
content, fiber yield, fiber quality, abiotic stress tolerance, and/or nitrogen use efficiency of a plant.
Patent AU-2020272564-A1 (AU)
Title: Pressure reducing valve with shut-off mechanism
Inventor: GAZIT BAR
IPC: G05D16/10
Filed: 2020-04-02
Abstract: A pressure regulator for regulating pressures within a portion of an irrigation system, can also be used to shut off downstream flow into the portion of the irrigation system in response to an incoming command arriving via an incoming port into the regulator.
Patent AU-2020289827-A1 (AU)
Title: Laser methods and systems for the aligned insertion of devices into a structure of the eye
Inventor: GRAY GARY
IPC: A61F9/008
Filed: 2020-12-17
Abstract: LASER METHODS AND SYSTEMS FOR THE ALIGNED INSERTION OF DEVICES 
INTO A STRUCTURE OF THE EYE 
Abstract 
Systems, methods and apparatus for replacement of cataractous lenses, the insertions of devices 
into the eye, and the alignment of IOLs, including toric OLs. Systems, methods and apparatus for 
forming laser cut capsulotomies having alignment nubs that are aligned with an astigmatic axis of 
the eye.
Patent AU-2020290672-A1 (AU)
Title: Novel spirobicyclic intermediates
Inventor: VERHOEVEN JONAS
IPC: C07D307/94
Filed: 2020-06-11
Abstract: The present invention relates to novel spirobicyclic intermediates useful in the synthesis of spirobicyclic nucleoside analogues.
Patent AU-2020341808-A1 (AU)
Title: Methods and systems for RNA-seq profiling
Inventor: GIERAHN TODD
IPC: C12Q1/6844
Filed: 2020-09-04
Abstract: Disclosed herein are methods for counting nucleic acid molecules (e.g., RNA molecules) of a sample by randomly truncating the nucleic acid molecules at a truncation base position within the nucleic acid molecules to produce truncated nucleic acid molecules, amplifying and sequencing the truncated nucleic acid molecules to produce sequencing reads, aligning the sequencing reads to a reference sequence to produce aligned sequencing reads, and identifying a number of nucleic acid molecules using truncation locations of aligned sequencing reads. Also disclosed herein are methods for constructing sequencing libraries that preserve truncation positions of the nucleic acid molecules. Also disclosed herein are methods for depleting or enriching a sample for one or more target sequences, using sets of blocking oligonucleotides corresponding to the one or more target sequences.
Patent AU-2020348817-A1 (AU)
Title: Anti-alpha-hemolysin antibody and use thereof
Inventor: AN MAOMAO
IPC: C07K16/12
Filed: 2020-09-18
Abstract: Provided are an antibody that binds to Staphylococcus aureus alpha-hemolysin or a fragment thereof, and the use of the antibody or the fragment thereof for preventing or treating Staphylococcus aureus infections. The antibody is obtained through screening by means of the strategies of attenuated immunity and virulent screening of alpha-hemolysin, and the antibody has high affinity to alpha-hemolysin, can effectively block the hemolysis effect of alpha-hemolysin, has proved significant protective or therapeutic effects in the alpha-hemolysin sepsis model, MRSA bacteremia model and MRSA lung infection model, and has a synergistic effect with antibiotics, which is a beneficial supplement to existing antibiotic therapy for Staphylococcus aureus.
Patent AU-2020359626-A1 (AU)
Title: Systems and methods for guiding movement of a tool
Inventor: BOWLING DAVID GENE
IPC: A61B34/00
Filed: 2020-09-30
Abstract: Systems and methods are provided for guiding movement of a tool. The system comprises a tool and a manipulator. A guide handler obtains a target state for the tool and generates virtual constraints based on the target state and a current state of the tool. A constraint solver calculates a constraint force adapted to attract the tool toward the target state or repel the tool away from the target state based on the virtual constraints. A virtual simulator simulates dynamics of the tool in a virtual simulation based on the constraint force and input from one or more sensors, to output a commanded pose. The control system commands the manipulator to move the tool based on the commanded pose to thereby provide haptic feedback to the user that guides the user toward placing the tool at the target state or away from the target state.
Patent AU-2020361620-A1 (AU)
Title: Delivery systems and devices for the treatment of benign prostatic hyperplasia and related lower urinary tract symptoms
Inventor: CHANG KENNETH CHIH-PING
IPC: A61F2/90
Filed: 2020-10-09
Abstract: Devices and systems are disclosed for managing and/or treating body tissues obstructing a hollow body lumen, including the prostatic lobe tissues obstructing the urethra, for example conditions including benign prostatic hyperplasia (BPH), bladder outlet obstruction (BOO), benign prostatic obstruction (BPO) and associated lower urinary tract symptoms (LUTS). An implant is maintained in a constrained configuration within a distal portion of an elongated sheath so that is may be deployed by driving the implant with a pusher coaxially disposed within the sheath. An implant engaging element helps maintain control of the implant during deployment.
Patent AU-2020383932-A1 (AU)
Title: Improved systems and methods for secure data input and authentication
Inventor: PIKE JUSTIN
IPC: G06F21/36
Filed: 2020-11-09
Abstract: Improved methods and systems for secure data entry and/or authentication of a user are provided. A preferred method of the invention comprises: selecting a keypad zone within an area of a display zone of a touch screen which comprises a plurality of hotspots that implement the keys of an operable keypad; providing an image of a keypad at the same location as the keypad zone such that the keypad image covers the operable keys within the keypad zone and the keypad image functions as a visible mask or cover over the operable keys of the keypad zone; a new keypad zone is selected at a different location within the display zone when the process is subsequently repeated, such that the keypad zone and the image are re-positioned to provide an operable keypad and overlaid, masking keypad image in a new area of the screen.
Patent AU-2020419183-A1 (AU)
Title: Temperature-based transient delivery of ZSCAN4 nucleic acids and proteins to cells and tissues
Inventor: KO MINORU S H
IPC: A61K48/00
Filed: 2020-12-30
Abstract: The present disclosure relates to methods for transiently activating temperature-sensitive agents in one or more cells, for example by contacting one or more cells with a temperature-sensitive agent and transiently incubating the cells at a permissive temperature for inducing an activity of the temperature-sensitive agent in the cells. Additionally, the present disclosure relates to methods of contacting one or more cells in a subject with a temperature-sensitive agent and then lowering the subject's body temperature to a permissive temperature for inducing an activity of the temperature-sensitive agent in the cells. The disclosure also relates to methods of treating a subject with a temperature-sensitive therapeutic agent. In particular, the disclosure provides tools for temperature-sensitive delivery of ZSCAN4 nucleic acids and proteins to cells.
Patent AU-2020456975-A1 (AU)
Title: System and method for real-time monitoring progression of low back pain rehabilitation
Inventor: IBRAHIM FATIMAH
IPC: A61B5/24
Filed: 2020-10-19
Abstract: The present invention discloses a system and a method for monitoring a progression of low back pain rehabilitation in a real-time manner. The system comprises a wearable electromyography, EMG, assembly comprising a plurality of detection electrodes deployed on erector spinae muscles at a lumbar region of vertebrae L4 and L5, a signal detection module, an acquisition and transmission module, an inertia measurement module, and a monitoring and reporting unit. The monitoring and reporting unit determines, based on digital EMG signal, a flexion relaxation ratio, FRR, and an extension relaxation ratio, ERR, associated with the said erector spinae muscles, and compares the same against that of a historical data to determine the said rate of improvement or deterioration.
Patent WO-2022032345-A1 (WO)
Inventor: NAPIER ANDREW
IPC: C22B7/00
Filed: 2021-08-12
Abstract: The present disclosure relates generally to processes for recovering values from batteries. More specifically, the present disclosure relates to processes for recovering an electrode material from lithium-ion batteries, such as an electrode material comprising a cathode material and/or an anode material, for example a mixed metal material (MMD).
Patent WO-2022104414-A1 (WO)
Inventor: BURN PAUL LESLIE
IPC: G01N21/64
Filed: 2021-11-17
Abstract: La divulgation concerne un procédé de détection d'un agent nerveux dans un analyte, ledit agent nerveux ayant une liaison phosphore-fluor, ledit procédé comprenant les étapes consistant à : (a) Mettre en contact l'analyte avec une composition à l'état solide comprenant un composé capteur ; le composé capteur comprenant un atome d'azote basique et une fraction hydroxyaryle protégée par un groupe protecteur silyle ; et en présence de fluorure d'hydrogène, ledit groupe silyle est clivé pour effectuer une déprotection du groupe hydroxyle formant ainsi un composé rapporteur luminescent ; (b) irradier la composition à l'état solide à une longueur d'onde prédéfinie ; (c) mesurer la luminescence pour déterminer si le composé rapporteur est présent ; et (d) déterminer si l'agent nerveux est présent dans l'analyte sur la base de la mesure obtenue à l'étape (c).
Patent AU-2021201148-A1 (AU)
Title: Raster design for narrowband operation for machine type communications
Inventor: RICO ALVARINO ALBERTO
IPC: H04W4/70
Filed: 2021-02-22
Abstract: Aspects of the present disclosure provide techniques for design of channel raster for 
narrowband operation. One example method, performed by a base station, generally 
includes determining, based on one or more conditions, an exact frequency location of 
one channel of one or more channels to perform narrowband communications with a 
user equipment. The method also includes transmitting an indication of the one or more 
conditions to the user equipment. The method further includes communicating with the 
UE, based at least in part on the exact frequency location of the one channel.
7/12 
700 
702 
PERFORM A CELL SEARCH IN ONE OR MORE 
CHANNELS 
704 
DETERMINE THAT A CELL IS PRESENT IN ONE 
CHANNELOFTHEONEORMORECHANNELS 
706 
DETERMINE, BASED ON ONE OR MORE CONDITIONS, 
AN EXACT FREQUENCY LOCATION OF THE ONE 
CHANNEL FOR NARROWBAND COMMUNICATIONS 
WITH A BASE STATION OF THE CELL 
708 
COMMUNICATE WITH THE BASE STATION, BASED AT 
LEAST IN PART ON THE EXACT FREQUENCY 
LOCATION OF THE ONE CHANNEL 
FIG. 7
Patent AU-2021201837-A1 (AU)
Title: Electronic file format modification and optimization
Inventor: SHELKSOHN MARCUS
IPC: G06Q20/36
Filed: 2021-03-24
Abstract: A method of electronic file format conversion and optimization includes requesting 
a second set of information following receipt of a first set of information used to transfer 
an electronic file on a website. The method includes receiving the second set of 
5 information from a first computing device associated with a first entity. The method 
includes receiving user input from a second computing device associated with a second 
entity that initiates transfer of the electronic file from the first computing device to the 
second computing device. In response to additional user input from the second computing 
device used to access the electronic file, the method includes accessing an additional set 
10 of information related to the electronic file and converting the electronic file to an 
optimized file based on the second information and the additional information. At least a 
version of the optimized file being formatted for display on the second computing device.
Patent AU-2021201878-A1 (AU)
Title: Game account access device
Inventor: ASHER JOSEPH M
IPC: A63F9/00
Filed: 2021-03-25
Abstract: Systems and methods for verifying the eligibility of players attempting to participate in gaming 
events are disclosed. Communication objects having RFID tags and closed electrical circuits 
are individually assigned to and worn by players within a gaming player verification system, 
which can be administrated by a casino desk, hotel concierge, or other operating entity. These 
RFID tags are adapted to communicate with associated player tracking units attached to gaming 
machines and other devices via radio frequency waves, and each communication object is 
adapted to alter its communication pattern in response to any break of its closed electrical 
circuit. Bracelets, wristwatches or collars can be used as communication objects, such that the 
removal of such an object from the player cannot be accomplished without breaking the closed 
electrical circuit contained therein, thereby disabling or de-authenticating the device.
WO 2008/127810 PCT/US2008/056120 
1/6 
10 
34 33 
30 
29 
28 31 
26 32 
21 
35 
212 
25 
22 
23 
24 
20 
FIG. I
Patent AU-2021205133-A1 (AU)
Title: Pyridyl inhibitors of hedgehog signalling
Inventor: GUNZNER JANET
IPC: C07F9/142
Filed: 2021-07-19
Abstract: The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for 
treating malignancies where the compounds have the general formula I: 
wherein A, X, Y RI, R2, R3, R4, m and n are as described herein.
Patent AU-2021213956-A1 (AU)
Title: Improved assay for determining neutralising antibody titre to a viral vector
Inventor: FOLEY JONATHAN
IPC: C12N15/86
Filed: 2021-01-28
Abstract: The present invention relates to an improved assay and in particular to an improved assay that is capable of consistently measuring antibody titre, especially neutralising antibody (NAb) titre, at lower thresholds and/or with greater speed than conventionally-known assays. The invention further relates to use of such assays in combination with the provision of gene therapy and/or in combination with the provision of methods aimed at removal/depletion of neutralising antibodies from a patient.
Patent AU-2021229710-A1 (AU)
Title: CPG-adjuvanted SARS-CoV-2 virus vaccine
Inventor: MEINKE ANDREAS
IPC: A61K39/12
Filed: 2021-04-06
Abstract: Described herein are CpG-adjuvanted SARS-CoV-2 vaccines and compositions and methods of producing and administering said vaccines to subjects in need thereof.
Patent AU-2021237122-A1 (AU)
Title: Antiviral composition for oral care
Inventor: MIZIKOVSKY DALIA
IPC: A61K8/06
Filed: 2021-03-17
Abstract: Viral infection of the oral mucosa (the lining of the oral cavity) is a common feature of many respiratory viruses that is central to pathogenesis and spread. Despite this, few anti-viral oral hygiene products exist. The present invention is a composition of a zinc salt and hinokitiol to be used as an anti-viral agent in oral care products. The composition is extremely low risk for adverse effects and irritation, and as such can be used continuously and frequently as both a preventative measure and a treatment. Oral care products in which this composition may be used include, but are not limited to toothpaste, mouth rinse and gargling solution. The composition inhibits viral replication in the oral cavity through interacting with the replication machinery of the viruses.
Patent AU-2021239088-A1 (AU)
Title: Methods, database and system for use with viral infection
Inventor: LAPIDOT YARON
IPC: A61B5/08
Filed: 2021-03-18
Abstract: The invention disclosed herein concerns screening and detecting compounds associated with viral replication and use thereof for early detection of a variety of viral infections.
Patent AU-2021250481-A1 (AU)
Title: Flow assay cartridge
Inventor: RENNIE ROB J
IPC: G01N33/558
Filed: 2021-04-02
Abstract: A flow assay cartridge for housing and protecting a flow assay membrane or lateral flow test strip which can be vertically stacked and is adapted for high-throughput automated lateral flow assay testing and analysis. The flow assay cartridge comprises a base and lid for receiving the flow assay membrane, and top and bottom engagement features such that two or more flow assay cartridges can be releasably adjoined in a vertical orientation such that they can be easily handled by an automated assay apparatus.
Patent AU-2021250721-A1 (AU)
Title: Aqueous foaming composition and use thereof for the prevention and/or inhibition of aerosol formation from the rebound of a liquid on a surface
Inventor: LISO ARCANGELO
IPC: C11D1/90
Filed: 2021-03-19
Abstract: The invention relates to a new aqueous foaming composition particularly effective in preventing and/or inhibiting the formation of aerosols from the rebound of a liquid on a surface, more particularly from the rebound of urine on the external and/or internal surface of a toilet. The aqueous foaming composition of the invention comprises at least one betaine, at least one anionic surfactant, at least one dialkyl carbonate, at least one fatty alcohol with a linear or branched, saturated or unsaturated alkyl chain containing at least 4 carbon atoms, at least one fatty acid ester with a linear or branched, saturated or unsaturated alkyl chain containing at least 4 carbon atoms and, optionally, at least one pH regulator, at least one deodorizing substance and/or a propellant gas.
Patent AU-2021252906-A1 (AU)
Title: Anti-obesity peptides and uses thereof
Inventor: JUNG MINJIN
IPC: A61K38/00
Filed: 2021-04-06
Abstract: Provided herein are compositions and methods for treating obesity. In particular, provided herein are anti-obesity peptides and uses of such peptides in the treatment and prevention of obesity and related medical conditions. Further disclosed are the sequences of anti- obesity peptides, wherein the peptides can be cyclized via the addition of a cysteine to each end of the said peptides.